CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 9 No. 5
The Lerner et al Article Reviewed 

Morbidity of Contemporary Radical Retropubic Prostatectomy for Localized Prostate Cancer

By

Mark S. Soloway, MD, University of Miami School of Medicine, Miami | May 1, 1995


Radical prostatectomy is not only the most common operation performed by most urologic oncologists, but also probably now represents the most common open operative procedure performed by all urologists in the United States. Much of this dramatic increase is due to the use of prostate-specific antigen (PSA) as a method for early diagnosis. My own experience is not unusual, in that approximately 50% of my male patients who underwent a radical prostatectomy last year had clinical stage T1c prostate cancer, meaning that the digital rectal exam was normal. The diagnostic biopsy was performed because of an elevated PSA.

Five years ago it was unusual to detect prostate cancer in men 50 to 60 years old. Now it is not uncommon. Until there is evidence to the contrary, most urologists perceive that total prostatectomy is the best method to cure prostate cancer in men under age 70 years. Other alternatives explored with the patient who has apparent organ-confined prostate cancer include external-beam radiation therapy, the experimental approach of cryotherapy, and, possibly, interstitial radiation therapy. In patients over 75 years of age who have any significant comorbidity, watchful waiting is discussed, and in this circumstance may be the most reasonable choice.

Increasingly, patients are aware of the side effects associated with total prostatectomy. Not infrequently, a newly diagnosed patient will have spoken with someone who has undergone a radical prostatectomy. Thus, it is imperative that clinicians have an excellent understanding of the side effects associated with total prostatectomy and the other treatment options.

Dramatic Decline in Perioperative Morbidity

The perioperative morbidity of total prostatectomy has declined dramatically in the last few years. It is remarkable that Dr. Lerner and his fellow Mayo Clinic urologists did not have a single operative death in 1,000 consecutive procedures. In their review, they report that only 22% of patients required a blood transfusion. Many urologists request that the patient donate one or two units of blood prior to surgery. If this is done, the likelihood of receiving blood from a blood bank is very low. In my last 100 consecutive radical prostatectomies, no patient required other than autologous blood.

The hospital stay for this procedure also has declined. My experience in Miami is not dissimilar from that of Lerner et al. Patients are often admitted on the day of surgery, and the average stay has decreased from 6 to 4 days. The reasons for the reduction in hospital stay include early ambulation, initiation of a liquid diet on postoperative day 1 or 2, a reduction in the use of narcotics for pain management, and pressure from third-party payors. Encouraging patients to aim for discharge on day 3 or 4 is an important strategy toward achieving that goal.

Urinary Incontinence an Important Issue

With the dramatic reduction in perioperative morbidity, the two primary concerns are urinary incontinence and erectile dysfunction. Although both are important, significant urinary incontinence is perhaps the most important quality-of-life issue. Men who have significant incontinence are depressed and actively seek treatment. Unfortunately, if incontinence is severe, the treatments, although helpful, are usually imperfect. These include periurethral injection of collagen(Drug information on collagen) or Teflon and the placement of an artificial urinary sphincter. Although the success rate of these measures is reported to be between 60% and 90%, rarely do the results meet the expectations of the patient.

Thus, it is imperative to minimize the chance of significant urinary incontinence. Fortunately, there are some technical modifications that, I believe, can reduce the risk of "significant" urinary incontinence. The surgeon should minimize dissection of the urethra distal to the apex of the prostate, as well as strive to gain adequate urethral length distal to the apex.

Although some of my colleagues disagree, I believe that bladder neck preservation is important. Preservation of the proximal urethra as it exits from the urinary bladder reduces the likelihood of an anastomotic stricture. Of my last 134 consecutive patients who underwent a radical prostatectomy with bladder neck preservation, only 2 (1.4%) developed an anastomotic stricture. Such stricture is often accompanied by some degree of urinary incontinence and may require surgical correction for voiding complaints. The fibrosis contributes to the incontinence. In addition, maintaining an intact bladder neck and proximal urethra may facilitate the early return of continence.

We recently conducted a quality-of-life analysis of 79 patients who underwent radical prostatectomy [1]. Among the 51 patients evaluated 12 months after radical prostatectomy, when asked "How often are you wet with coughing or sneezing?", 67% said never, 29% said occasionally, and 4% indicated always. In response to the question, "How often does a drip occur without warning?", 61% said never, 33% indicated occasionally, and 6% said always. With regard to whether they wear a pad, 78% of the patients indicated that this was never necessary, while 10% reported needing pads occasionally and 12% constantly. When asked, "How do you feel about wetting as an issue in your life?", 61% stated it was no problem, 33% rated their minor incontinence on a scale of 1 to 5 and only one scored it as a 5 (terrible), and 6% regarded it as a big problem. This indicates that in a small percentage of patients (approximately 5% to 10%), urinary incontinence is a quality-of-life issue.

Rate of Erectile Dysfunction Varies

The published incidence of erectile dysfunction following radical prostatectomy varies considerably. Several factors correlate with the likelihood of erectile dysfunction, including the patient's age, whether or not the neurovascular bundles were preserved, and, importantly, preoperative potency. Few studies have examined penile tumescence before and after surgery. Most studies have relied on questionnaires filled out by patients.

Fowler et al [2] reviewed a Medicare population in the New England area and found that 11% of radical prostatectomy patients were able to achieve erections sufficient for intercourse. In our study, 65% of patients described their sexual function as unsatisfactory [1]. Fortunately, with the increasing use of intracavernosal vasoactive substances, most interested men can achieve erections sufficient for intercourse.

We analyzed the age of patients reporting sexual dysfunction. We anticipated that, as patients get older, the risk of preoperative impotence would rise, and the role that sexuality plays in a relationship would therefore fall. This was not supported by our data. Men over 65 years old were as likely to regard postoperative impotence as a major issue as men under the age of 65. Accordingly, many people appear to have sexual relations well into their 70s. As the number of patients analyzed was small, the impact of aging on sexuality was difficult to detect statistically.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.



Seth E. Lerner, MD, Michael L. Blute, MD, Michael M. Lieber, MD, Horst Zincke, MD, PhD


1. Braslis K, Santa-Cruz C, Brickman AL, et al: Quality of life twelve months after radical prostatectomy. Brit J Urol 75:48-53, 1995.

2. Fowler F., Roman J, Barry MJ, et al: Patients reported complications and follow-up treatment after radical prostatectomy: The national Medicare experience. Urology 42:622-629, 1993.



 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 52-Year-Old Man Presents With an Erythematous Lesion
Cesar Moran, MD , May 22, 2013

A 52-year-old man presented with an erythematous lesion in the axilla of unknown duration. Surgical excision was performed. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy